INTRODUCTION
Vancomycin, an amphoteric and high-molecular-weight complex tricyclic glycopeptide antibiotic, available in the form of water-soluble hydrochloride, is often used for treating severe hospital infections.
1
Vancomycin concomitantly inhibits the cell wall synthesis of susceptible microorganismsorbacteria,alteringcytoplasm membrane permeability and interfering with RNAsynthesis. 2 Itsmostsigniicantadverseeffectsareototoxicityandnephrotoxicity. Marinho (2005) hasreportedthatapproximately30%of patients have experienced some adverse reactiontovancomycin,suchasrenalfailure(18%), thrombocytopenia(7%),neutropenia(2%),red mansyndrome(2%),andototoxicity(1%). 3 Theincreaseduseofvancomycinhasbeen attributedtotheincreaseofnosocomialinfectionscausedbymethicillin-resistantStaphylococcus aureus (MRSA), which increased from 2%in1974tomorethan50%in2000. Bacterialinfectionsmostoftenoccurinhemodialysis (HD) patients. This is most probably related to frequent violation of normal skin and mucosa barriers than to immune dysfunction. Bacterial infections in HD patients progress more rapidly and resolve less promptly than those in non-uremic patients. 5 Venousaccesssiteisthesourceof50%to80% ofthebacteremiaepisodesindialysispatients. Bacteremiacanleadtoendocarditis,meningitis,osteomyelitis,paraspinalabscess,orformation of septic embolus.Arteriovenous istulas donothaveanexitsite,thusbeingassociated withlowerinfectionrates. 6 InHDpatients,infectionscausedbyGrampositive bacteria can be treated with vancomycin,mainlyduetoitsactivityagainstmost Gram-positive pathogens, especially MRSA. Moreover, vancomycin has a long half life in renal failure, which allows using intermittent dosesregimes. 7 However,thepharmacokinetic characteristicsofthisantibioticshouldberespectedtomaintainadequatelevels,minimize the appearance of resistant strains, and avoid toxicity. 8 Changesinrenalfunctionassociated withnormalagingorwithdiseasescanhavea deepeffectonthepharmacologyofantibiotics, whichrequiretheirdosestobeadjusted. 9, 10, 11 The amount of vancomycin removed by HD is negligible when conventional dialyzers areused;however,whenusinghigh-flowmembranedialyzers,asigniicantreductioninvancomycinlevelscanoccur. 5, 11 Measurement of vancomycin serum levels inpatientswithrenalfailureisrequiredtoas-
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Due to the high variability of the minimum inhibitory concentrations (MIC) for vancomycin-susceptible staphylococcusstrains,arecentstudyhasrecommended thatvancomycinlevelsrangefrom5to10timestheMIC value. 12 ThesuggesteddoseofvancomycinforHDpatientsis 15mg/kgevery7to10days. 13 However,whenhigh-flow membranesareusedinHD,additionalvancomycindoses arerecommendedateveryHDsession.
14 LentinoandLeehey(2001)haverecommendedthattheintervalbetween vancomycindosesinHDpatientsshouldbeenlarged,but treatmentshouldbeginwithanattackdoseof20mg/kg andcontinuedwithsubsequentdosesof15mg/kgevery sevendaysaftertheHDsession. 5 Other authors have suggested changes in dosing and intervalaccordingtotheadministrationregimenandthe typeofdialyzerused.However,reviewingstudiesonthe pharmacokineticsofvancomycininHDpatientsshowed severallimitations,differentconclusionsandsuggestions ofdoseadjustmentcouldbeidentifiedasshowninTable 1. The divergences and limitations of the studies published have motivated the conduction of this study that aimedatmonitoringtheserumlevelsofvancomycinin HDpatientsandcheckingiftheconcentrationswereadequate.
METHOD
ThestudywasapprovedbytheResearchEthicsCommittee oftheUniversidadedeSorocaba(Protocol001/05)andby theTeachingandResearchCommitteeoftheConjuntoHospitalardeSorocaba(stateofSãoPaulo),astatepublichospitalthatattendsapproximately120HDpatients.Allpatients includedinthisstudyusedvancomycinduringtheperiod studied(fromNovember2006toMay2007)andprovided writteninformedconsent.Theexclusioncriteriawereasfollows:reportofallergytovancomycin,liverdisease,orprevioususeofvancomycinupto15daysbeforesamplecollec-tion.
Data collection from medical records included the following: gender, age, origin, and ethnicity. The results of culture and antibiogram were obtained from the Hospital InfectionControlServiceoftheConjuntoHospitalardeSorocaba.
Vancomycin(VancocinaCP-ABLAntibióticosdoBra-sil)wasgivenindoseof1gdilutedinto100mLof0.9%so-diumchloridesolutioninfusedduringthelasthourofHD, accordingtotheservice'sprotocol,whichrecommendsthe administrationof1geverysevendays.Bloodsampleswere collected by the nurse team in tubes containing ethylene diaminetetraaceticacid(EDTA)forhemogramandindry tubes for measuring vancomycin and albumin. Then, they were centrifuged and frozen. The collections for measuringvancomycinwereobtainedinsinglesamplesatthetime points48,96,120or168hoursafteradministeringtheirst doseofthedrug.
HemogramwasperformedintheautomatedABXPentra60® device, at the Instituto Diagnóstico de Sorocaba. Theendpointcolorimetricmethodwasusedformeasuring albumin with a kit containing bromocresol green (BCG) of Laborlab, at the Universidade de Sorocaba. Vancomycinserumlevelsweremeasuredbyusing150µLofserum and polarized light immunofluorescence with monoclonal antibodies (ABBOTT Laboratories kits) in the automated AxSym®device(ABBOTT),inthesectorofserologyofthe HemonúcleooftheConjuntoHospitalardeSorocaba.
The results were reported regarding the percentage of patients with inadequate serum concentrations and need fordoseadjustment.Statisticalanalyses(ANOVA)wereperformedinthecorrelationoftheresultsofvancomycinand albuminconcentrationsandhematocritlevels.Thesigniicancelevelof5%wasadopted.
RESULTS
The study comprised 17 patients, ive of whom used vancomycin more than once during the period studied, at a meanintervalof72days,addinguptothecollectionof22 samples.Theirmeanagewas56.9±6.0years.Mostpatients (56%)werefemale,married(65%),white(65%),andcame fromthemunicipalitiesoftheSorocabaregion(59%).
The following clinical conditions related to HD procedurestandout:double-lumencatheterasthemostcommon venous access (65%); dialysis capillary reuse time ranging from1-19days,medianofthreedays;associationofdiabetesmellitusandarterialhypertensionasthemostfrequent etiologyofchronicrenalfailure(41%);meanHDtimeof16 months.Allpatientsusedpolysulfonedialyzermembrane.
Patients' laboratory data presented in Table 2 showed thatalbumin(referencevalues:3.4-4.8g/dL) 21 andhematocrit(referencevalues:women:39-49%andmen:35-45%) 21 werebelownormalvalues,butcompatiblewiththesetting of chronic renal failure. Neither statistical difference between groups (ANOVA), nor correlation between the patient'splasmalevelofalbuminandserumconcentrationof vancomycinwereobserved(p>0.05).
Regarding to vancomycin serum concentrations , no statistical difference (ANOVA, p > 0.05) between the valuesofthefourgroupswasobserved(Table2).However,at least14%oftheresultswereinadequatewhenconsidering theminimumtroughconcentrationgreaterthan5µg/mL, and86%wereinadequatewhenconsideringtheminimum troughconcentrationgreaterthan10µg/mL(Figure1).
Staphylococciwereidentiiedinonethirdofthecases, and approximately 25% of the microorganisms isolated 10 Currently, approximately 80% of the hospital staphylococcal infections are treated with glycopeptides, suchasvancomycinandteicoplanin.Thisisstilltheantimicrobialclassofchoicefortreatinginfectionscaused by MRSA, although strains with reduced sensitivity to vancomycinhavealreadybeenisolatedinBrazil. 26 Because VRE are usually resistant to other antibiotics commonlyusedinhospitals,severeexposuretootherdrugs isassociatedwithahighriskofacquiringVRE. 27 Similarly to beta-lactam antibiotics, vancomycin has negligible post-antibiotic effects and requires the maintenanceofconcentrationsequivalenttofourtoivetimesMIC duringprolongedperiodstoobtainaneficientantibacterial effect. 8 InclinicalpracticeinBrazilianhospitals,dosingformost patients with chronic renal failure is 1 g every seven days. However, in a study by González-Martin et al. (1996) , the vancomycinlevelsevendaysafteradministrationwaslower than expected and a subtherapeutic level was probably achieveddaysbefore. 17 Zoeret al. (1997) haverecommendedaninitialvancomycindoseof1g,towhich500mgshouldbeaddeddur-ingeachsubsequentHDsessioninpatientswithapositive cultureforS.aureus.Theidealtimeforplasmamonitoring wouldoccur48h,and96hor120haftervancomycininfu-sion. 18 Otherauthorshaverecommendedthedetermination ofvancomycinserumconcentrationbeforetheirstHDsessionsubsequenttotheadministrationandbefore72-hour of HD session. If the results are below the recommended values(between5and10µg/mL),acomplementary500-mg doseofvancomycincanbeused. 5, 28 It is worth noting that, in this study, 86% of the patientshadconcentrationsbelow10µg/mLand14%ofthe patientshadconcentrationsbelow5µg/mL.Whenthecollectiontimesareconsidered,onecaninferthatthenumber ofpatientsreachingtroughconcentrationsbelow5µg/mL would be greater. It is also worth noting that vancomycin hasbeenadministeredduringtheHDsession,butsupplementarydosesarenotadministeredaccordingtotherecommendationofMasonet al. (2003) whohavecomparedthree regimensofvancomycindosing. 7 In conclusion, the patients included in this study were exposedtoantibioticsubtherapeuticdoses.Consideringthe increasedriskofselectingresistantmicroorganisms,monitoringofvancomycinserumconcentrationinHDpatients isrecommended.
